Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1792


Augmenter of liver regeneration: A fundamental life protein.

Nalesnik MA, Gandhi CR, Starzl TE.

Hepatology. 2017 Jul;66(1):266-270. doi: 10.1002/hep.29047. Epub 2017 May 22. Review. No abstract available.


Thomas Starzl, Video Interview for His Living Legend Award at the ISBTS 2015.

Gondolesi GE, Mazariegos G, Starzl TE.

Transplant Proc. 2016 Mar;48(2):444-9. doi: 10.1016/j.transproceed.2016.02.008.


Paul Terasaki September 10, 1929--January 26, 2016.

Starzl TE.

Clin Transplant. 2016 Mar;30(3):181-2. doi: 10.1111/ctr.12716. No abstract available.


Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice.

Gandhi CR, Chaillet JR, Nalesnik MA, Kumar S, Dangi A, Demetris AJ, Ferrell R, Wu T, Divanovic S, Stankeiwicz T, Shaffer B, Stolz DB, Harvey SA, Wang J, Starzl TE.

Gastroenterology. 2015 Feb;148(2):379-391.e4. doi: 10.1053/j.gastro.2014.10.008. Epub 2014 Oct 13.


The long reach of liver transplantation.

Starzl TE.

Exp Clin Transplant. 2013 Apr;11(2):87-92. No abstract available.


Human dominant-negative class II transactivator transgenic pigsĀ - effect on the human anti-pig T-cell immune response and immune status.

Hara H, Witt W, Crossley T, Long C, Isse K, Fan L, Phelps CJ, Ayares D, Cooper DK, Dai Y, Starzl TE.

Immunology. 2013 Sep;140(1):39-46. doi: 10.1111/imm.12107.


Fifty years later.

Mangan TL, Benedetti KA, Starzl TE.

Clin Transpl. 2013:105-9.


The long reach of liver transplantation.

Starzl TE.

Nat Med. 2012 Oct;18(10):1489-92. doi: 10.1038/nm.2927. No abstract available.


Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression.

Schneeberger S, Gorantla VS, Brandacher G, Zeevi A, Demetris AJ, Lunz JG, Metes DM, Donnenberg AD, Shores JT, Dimartini AF, Kiss JE, Imbriglia JE, Azari K, Goitz RJ, Manders EK, Nguyen VT, Cooney DS, Wachtman GS, Keith JD, Fletcher DR, Macedo C, Planinsic R, Losee JE, Shapiro R, Starzl TE, Lee WP.

Ann Surg. 2013 Feb;257(2):345-51. doi: 10.1097/SLA.0b013e31826d90bb.


The first report of orthotopic liver transplantation in the Western world.

Busuttil RW, De Carlis LG, Mihaylov PV, Gridelli B, Fassati LR, Starzl TE.

Am J Transplant. 2012 Jun;12(6):1385-7. doi: 10.1111/j.1600-6143.2012.04026.x. Epub 2012 Mar 28.


The shared trail of organ, limb, and face transplantation.

Starzl TE, Barker C.

Proc Am Philos Soc. 2011 Mar;155(1):1-12. No abstract available.


Treprostinil, a prostacyclin analog, ameliorates ischemia-reperfusion injury in rat orthotopic liver transplantation.

Ghonem N, Yoshida J, Stolz DB, Humar A, Starzl TE, Murase N, Venkataramanan R.

Am J Transplant. 2011 Nov;11(11):2508-16. doi: 10.1111/j.1600-6143.2011.03568.x. Epub 2011 Jun 10.


The mystique of organ transplantation: Ernst Knobil Distinguished Lecture, December 8, 2010.

Starzl TE.

Exp Clin Transplant. 2011 Apr;9(2):75-93. No abstract available.


Themes of liver transplantation.

Starzl TE, Fung JJ.

Hepatology. 2010 Jun;51(6):1869-84. doi: 10.1002/hep.23595. Review.


Kidney after nonrenal transplantation-the impact of alemtuzumab induction.

Shapiro R, Basu A, Tan HP, Morgan C, Sharma V, Blisard D, Randhawa PS, Dvorchik I, McCauley J, Ellis D, Marsh JW, Webber S, Kurland G, McCurry KR, Abu-Elmagd K, Mazariegos G, Starzl TE.

Transplantation. 2009 Sep 27;88(6):799-802. doi: 10.1097/TP.0b013e3181b4aaf5.


Species-dependent hepatic metabolism of immunosuppressive agent tacrolimus (FK-506).

Tata PN, Subbotina N, Burckart GJ, Muddiman DC, Gusev AI, Hercules DM, Starzl TE, Venkataramanan R.

Xenobiotica. 2009 Oct;39(10):757-65. doi: 10.1080/00498250903114478.


Complications of right lobe living donor liver transplantation.

Marsh JW, Gray E, Ness R, Starzl TE.

J Hepatol. 2009 Oct;51(4):715-24. doi: 10.1016/j.jhep.2009.04.023. Epub 2009 May 27.


The origin of clinical organ transplantation revisited.

Starzl TE, Barker C.

JAMA. 2009 May 20;301(19):2041-3. doi: 10.1001/jama.2009.644. No abstract available.


Transplant innovation and ethical challenges: what have we learned? A collection of perspectives and panel discussion.

Cooley DA, Fung JJ, Young JB, Starzl TE, Siegler M, Chen PW.

Cleve Clin J Med. 2008 Nov;75 Suppl 6:S24-9; discussion S30-2. No abstract available.


Successful salvage of mucormycosis infection of the forearm and osteomyelitis of the ulna.

Jones NF, Shin EK, Eo S, Starzl TE.

Hand (N Y). 2008 Dec;3(4):332-6. doi: 10.1007/s11552-008-9119-x. Epub 2008 Aug 6.


Kidney after Extrarenal Transplantation - The Impact of Alemtuzumab Induction.

Shapiro R, Basu A, Tan HP, Morgan C, Sharma V, Blisard D, Randhawa PS, Dvorchik I, McCauley J, Ellis D, Marsh JW, Webber S, Kurland G, McCurry K, Abu-Elmagd K, Mazariegos G, Starzl TE.

Transplantation. 2008 May;8(Suppl 2):439. No abstract available.


Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody.

Shapiro R, Zeevi A, Basu A, Tan HP, Kayler LK, Blisard DM, Thai NL, Girnita AL, Randhawa PS, Gray EA, Marcos A, Starzl TE.

Transplantation. 2008 Apr 27;85(8):1125-32. doi: 10.1097/TP.0b013e31816a8a6d.


Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation.

Toyokawa H, Nakao A, Bailey RJ, Nalesnik MA, Kaizu T, Lemoine JL, Ikeda A, Tomiyama K, Papworth GD, Huang L, Demetris AJ, Starzl TE, Murase N.

Liver Transpl. 2008 Mar;14(3):346-57. doi: 10.1002/lt.21378.


Augmenter of liver regeneration: an important intracellular survival factor for hepatocytes.

Thirunavukkarasu C, Wang LF, Harvey SA, Watkins SC, Chaillet JR, Prelich J, Starzl TE, Gandhi CR.

J Hepatol. 2008 Apr;48(4):578-88. doi: 10.1016/j.jhep.2007.12.010. Epub 2008 Jan 28.


Immunosuppressive therapy and tolerance of organ allografts.

Starzl TE.

N Engl J Med. 2008 Jan 24;358(4):407-11. doi: 10.1056/NEJMe0707578. No abstract available.


In memoriam--James S. Wolf.

Starzl TE, Shapiro R.

Am J Transplant. 2008 Jan;8(1):259-60. Epub 2007 Oct 31. No abstract available.


Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation.

Shapiro R, Ellis D, Tan HP, Moritz ML, Basu A, Vats AN, Kayler LK, Erkan E, McFeaters CG, James G, Grosso MJ, Zeevi A, Gray EA, Marcos A, Starzl TE.

Am J Transplant. 2007 Dec;7(12):2736-8. Epub 2007 Oct 1.


World's longest surviving liver-pancreas recipient.

Harary AM, Abu-Elmagd K, Thai N, Shapiro R, Todo S, Fung JJ, Starzl TE.

Liver Transpl. 2007 Jul;13(7):957-60.


Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy.

Ellis D, Shapiro R, Moritz M, Vats A, Basu A, Tan H, Kayler L, Janosky J, Starzl TE.

Transplantation. 2007 Jun 27;83(12):1563-70.


Francis D. Moore.

Starzl TE.

Proc Am Philos Soc. 2005 Dec;149(4):605-13. No abstract available.


Cold heparinized lactated Ringers with procaine (HeLP) preservation fluid in 266 living donor kidney transplantations.

Tan HP, Vyas D, Basu A, Randhawa P, Shah N, Donaldson J, Marcos A, Simmons RL, Starzl TE, Shapiro R.

Transplantation. 2007 Apr 27;83(8):1134-6.


Chronic allograft nephropathy score before sirolimus rescue predicts allograft function in renal transplant patients.

Basu A, Falcone JL, Tan HP, Hassan D, Dvorchik I, Bahri K, Thai N, Randhawa PS, Marcos A, Starzl TE, Shapiro R.

Transplant Proc. 2007 Jan-Feb;39(1):94-8.


Transplantation of en bloc pediatric kidneys when the proximal vascular cuff is too short.

Kayler LK, Blisard D, Basu A, Tan HP, McCauley J, Wu C, Marcos A, Starzl TE, Shapiro R, Molmenti E.

Transplantation. 2007 Jan 15;83(1):104-5. No abstract available.


Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes.

Thai NL, Khan A, Tom K, Blisard D, Basu A, Tan HP, Marcos A, Fung JJ, Starzl TE, Shapiro R.

Transplantation. 2006 Dec 27;82(12):1621-4.


Introduction of Carl Gustav Groth.

Starzl TE.

Transplantation. 2006 Dec 27;82(12):1572-3. No abstract available.


Functionally important glycosyltransferase gain and loss during catarrhine primate emergence.

Koike C, Uddin M, Wildman DE, Gray EA, Trucco M, Starzl TE, Goodman M.

Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):559-64. Epub 2006 Dec 28.


Protocol biopsies should not (yet) be the standard of care in pediatric renal transplant recipients.

Shapiro R, Starzl TE.

Pediatr Transplant. 2006 Nov;10(7):766-7. No abstract available.


Tolerance for organ recipients: a clash of paradigms.

Marcos A, Lakkis F, Starzl TE.

Liver Transpl. 2006 Oct;12(10):1448-51. No abstract available.


Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy.

Tan HP, Kaczorowski DJ, Basu A, Unruh M, McCauley J, Wu C, Donaldson J, Dvorchik I, Kayler L, Marcos A, Randhawa P, Smetanka C, Starzl TE, Shapiro R.

Am J Transplant. 2006 Oct;6(10):2409-17. Epub 2006 Aug 4.


Leslie Brent and the mysterious German surgeon.

Starzl TE.

Ann Surg. 2006 Jul;244(1):154-7. No abstract available.


Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation.

Shapiro R, Ellis D, Tan HP, Moritz ML, Basu A, Vats AN, Khan AS, Gray EA, Zeevi A, McFeaters C, James G, Jo Grosso M, Marcos A, Starzl TE.

J Pediatr. 2006 Jun;148(6):813-8.


Pancreatic transplantation at the University of Pittsburgh.

Thai NL, Abu-Elmagd K, Khan A, Bond G, Basu A, Tom K, Mazariegos G, Sindhi R, Reyes J, Tan HP, Marcos A, Starzl TE, Shapiro R.

Clin Transpl. 2004:205-14.


Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism.

Nakao A, Toyokawa H, Kimizuka K, Nalesnik MA, Nozaki I, Bailey RJ, Demetris AJ, Starzl TE, Murase N.

Blood. 2006 Aug 15;108(4):1413-20. Epub 2006 Apr 25.


Generation of cloned transgenic pigs rich in omega-3 fatty acids.

Lai L, Kang JX, Li R, Wang J, Witt WT, Yong HY, Hao Y, Wax DM, Murphy CN, Rieke A, Samuel M, Linville ML, Korte SW, Evans RW, Starzl TE, Prather RS, Dai Y.

Nat Biotechnol. 2006 Apr;24(4):435-6. Epub 2006 Mar 26.


The difficulty of eliminating donor leukocyte microchimerism in rat recipients bearing established organ allografts.

Kiyomoto T, Toyokawa H, Nakao A, Kaizu T, Demetris AJ, Starzl TE, Murase N.

Transplantation. 2006 Feb 15;81(3):438-44.


The unfinished legacy of liver transplantation: emphasis on immunology.

Starzl TE, Lakkis FG.

Hepatology. 2006 Feb;43(2 Suppl 1):S151-63. Review.


The course of type 1 hepato-renal syndrome post liver transplantation.

Marik PE, Wood K, Starzl TE.

Nephrol Dial Transplant. 2006 Feb;21(2):478-82. Epub 2005 Oct 25.

Supplemental Content

Loading ...
Support Center